BIOCON - IntraDay Trade Analysis with Live Signals
Last Updated Time : 20 Dec 25, 07:02 am
Back to IntraDay Trade ListIntraDay Trade Rating: 3.5
| Stock Code | BIOCON | Market Cap | 53,285 Cr. | Current Price | 399 ₹ | High / Low | 425 ₹ |
| Stock P/E | 664 | Book Value | 120 ₹ | Dividend Yield | 0.13 % | ROCE | 2.09 % |
| ROE | 0.40 % | Face Value | 5.00 ₹ | DMA 50 | 384 ₹ | DMA 200 | 365 ₹ |
| Chg in FII Hold | 0.57 % | Chg in DII Hold | -0.77 % | PAT Qtr | 70.9 Cr. | PAT Prev Qtr | -8.30 Cr. |
| RSI | 52.4 | MACD | -0.25 | Volume | 38,77,660 | Avg Vol 1Wk | 19,46,973 |
| Low price | 291 ₹ | High price | 425 ₹ | PEG Ratio | -35.7 | Debt to equity | 0.16 |
| 52w Index | 80.3 % | Qtr Profit Var | 2,116 % | EPS | 5.51 ₹ | Industry PE | 30.6 |
📊 Analysis: Biocon shows cautious intraday potential. Current price (₹399) is above both 50DMA (₹384) and 200DMA (₹365), indicating medium-term strength. RSI at 52.4 is neutral, while MACD (-0.25) is slightly negative, suggesting weak short-term momentum. Volume (38,77,660) is significantly above weekly average (19,46,973), providing strong liquidity for intraday trades. However, extremely high P/E (664) compared to industry PE (30.6) and weak ROCE/ROE limit attractiveness.
💹 Optimal Buy Price: Around ₹392–396 (near support zone).
🎯 Profit-Taking Levels: ₹410–420 (short-term resistance).
🛡️ Stop-Loss: ₹385 (below 50DMA support).
⏱️ If Already Holding: Consider exiting if price fails to sustain above ₹400 with weakening momentum (RSI dropping below 50 or MACD staying negative). Exit near ₹410–420 if momentum improves; cut positions if price slips below ₹385 with rising volume.
Positive
- 📈 Strong quarterly PAT recovery (₹70.9 Cr. vs -₹8.3 Cr.).
- 💹 EPS at ₹5.51, showing earnings turnaround.
- 📊 FII holding increased (+0.57%).
- 📈 Stock trading at 80.3% of 52-week high range.
Limitation
- ⚠️ Extremely high P/E (664) vs industry PE (30.6).
- 📉 Weak ROCE (2.09%) and ROE (0.40%).
- ⚠️ Negative PEG ratio (-35.7), indicating poor valuation relative to growth.
Company Negative News
- 📉 DII holding reduced (-0.77%).
Company Positive News
- 📈 Quarterly profit surged (+2,116% variation).
- 💹 FII confidence with increased stake.
Industry
- 🏭 Industry PE at 30.6, much lower than Biocon’s valuation (664).
- 📊 Pharma sector supported by demand for biosimilars and generics.
Conclusion
⚖️ Biocon is a cautious intraday candidate today. Buy near ₹392–396, target ₹410–420, and protect downside at ₹385. If already holding, monitor RSI and MACD closely for exit signals. Strong liquidity and profit recovery support trades, but extreme valuation and weak fundamentals require tight risk management.
Would you like me to extend this into a sector benchmarking overlay against peers like Sun Pharma, Dr. Reddy’s, and Cipla to compare intraday strength?
Back to IntraDay Trade ListNIFTY 50 - Today Top Intraday Trade Stock Picks
NEXT 50 - Today Top Intraday Trade Stock Picks
MIDCAP - Today Top Intraday Trade Stock Picks
SMALLCAP - Today Top Intraday Trade Stock Picks